|
1
|
DeSantis CE, Bray F, Ferlay J,
Lortet-Tieulent J, Anderson BO and Jemal A: International variation
in female breast cancer incidence and mortality rates. Cancer
Epidemiol Biomarkers Prev. 24:1495–1506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Servick K: Breast cancer. Breast cancer: A
world of differences. Science. 343:1452–1453. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Malvezzi M, Bertuccio P, Levi F, La
Vecchia C and Negri E: European cancer mortality predictions for
the year 2012. Ann Oncol. 23:1044–1052. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Golse N and Adam R: Liver metastases from
breast cancer: What role for surgery? Indications and Results. Clin
Breast Cancer. 17:256–265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soni A, Ren Z, Hameed O, Chanda D, Morgan
CJ, Siegal GP and Wei S: Breast cancer subtypes predispose the site
of distant metastases. Am J Clin Pathol. 143:471–478. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Savci-Heijink CD, Halfwerk H, Hooijer GK,
Horlings HM, Wesseling J and van de Vijver MJ: Retrospective
analysis of metastatic behaviour of breast cancer subtypes. Breast
Cancer Res Treat. 150:547–557. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
O'Reilly SM, Richards MA and Rubens RD:
Liver metastases from breast cancer: The relationship between
clinical, biochemical and pathological features and survival. Eur J
Cancer. 26:574–577. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wyld L, Gutteridge E, Pinder SE, James JJ,
Chan SY, Cheung KL, Robertson JF and Evans AJ: Prognostic factors
for patients with hepatic metastases from breast cancer. Br J
Cancer. 89:284–290. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Atalay G, Biganzoli L, Renard F, Paridaens
R, Cufer T, Coleman R, Calvert AH, Gamucci T, Minisini A, Therasse
P, et al: Clinical outcome of breast cancer patients with liver
metastases alone in the anthracycline-taxane era: A retrospective
analysis of two prospective, randomised metastatic breast cancer
trials. Eur J Cancer. 39:2439–2449. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Duan XF, Dong NN, Zhang T and Li Q: The
prognostic analysis of clinical breast cancer subtypes among
patients with liver metastases from breast cancer. Int J Clin
Oncol. 18:26–32. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rossi M, Carioli G, Bonifazi M, Zambelli
A, Franchi M, Moja L, Zambon A, Corrao G, La Vecchia C, Zocchetti C
and Negri E: Trastuzumab for HER2+ metastatic breast cancer in
clinical practice: Cardiotoxicity and overall survival. Eur J
Cancer. 52:41–49. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Toft DJ and Cryns VL: Minireview:
Basal-like breast cancer: From molecular profiles to targeted
therapies. Mol Endocrinol. 25:199–211. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rouzier R, Perou CM, Symmans WF, Ibrahim
N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P,
et al: Breast cancer molecular subtypes respond differently to
preoperative chemotherapy. Clin Cancer Res. 11:5678–5685. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Largillier R, Ferrero JM, Doyen J,
Barriere J, Namer M, Mari V, Courdi A, Hannoun-Levi JM, Ettore F,
Birtwisle-Peyrottes I, et al: Prognostic factors in 1,038 women
with metastatic breast cancer. Ann Oncol. 19:2012–2019. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Follana P, Barriere J, Chamorey E,
Largillier R, Dadone B, Mari V, Hannoun-Levi JM, Marcy M, Flipo B
and Ferrero JM: Prognostic factors in 401 elderly women with
metastatic breast cancer. Oncology. 86:143–151. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leone JP, Leone J, Zwenger AO, Iturbe J,
Leone BA and Vallejo CT: Prognostic factors and survival according
to tumour subtype in women presenting with breast cancer brain
metastases at initial diagnosis. Eur J Cancer. 74:17–25. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martin AM, Cagney DN, Catalano PJ, Warren
LE, Bellon JR, Punglia RS, Claus EB, Lee EQ, Wen PY, Haas-Kogan DA,
et al: Brain metastases in newly diagnosed breast cancer: A
population-based study. JAMA Oncol. 3:1069–1077. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Leone BA, Vallejo CT, Romero AO,
Machiavelli MR, Pérez JE, Leone J and Leone JP: Prognostic impact
of metastatic pattern in stage IV breast cancer at initial
diagnosis. Breast Cancer Res Treat. 161:537–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gong Y, Liu YR, Ji P, Hu X and Shao ZM:
Impact of molecular subtypes on metastatic breast cancer patients:
A SEER population-based study. Sci Rep. 7:454112017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu SG, Li H, Tang LY, Sun JY, Zhang WW, Li
FY, Chen YX and He ZY: The effect of distant metastases sites on
survival in de novo stage-IV breast cancer: A SEER database
analysis. Tumour Biol. 39:10104283177050822017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Scrucca L, Santucci A and Aversa F:
Competing risk analysis using R: An easy guide for clinicians. Bone
Marrow Transplant. 40:381–387. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao HY, Gong Y, Ye FG, Ling H and Hu X:
Incidence and prognostic factors of patients with synchronous liver
metastases upon initial diagnosis of breast cancer: A
population-based study. Cancer Manag Res. 10:5937–5950. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang M, Zhang J, Ji S, Shao G, Zhao K,
Wang Z and Wu A: Transarterial chemoembolisation for breast cancer
with liver metastasis: A systematic review. Breast. 36:25–30. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tewes M, Peis MW, Bogner S, Theysohn JM,
Reinboldt MP, Schuler M and Welt A: Hepatic arterial infusion
chemotherapy for extensive liver metastases of breast cancer:
Efficacy, safety and prognostic parameters. J Cancer Res Clin
Oncol. 143:2131–2141. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang H, Liu B, Long H, Zhang F, Wang S and
Li F: Clinical study of radiofrequency ablation combined with TACE
in the treatment of breast cancer with liver metastasis. Oncol
Lett. 14:2699–2702. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kimbung S, Loman N and Hedenfalk I:
Clinical and molecular complexity of breast cancer metastases.
Semin Cancer Biol. 35:85–95. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kwast AB, Voogd AC, Menke-Pluijmers MB,
Linn SC, Sonke GS, Kiemeney LA and Siesling S: Prognostic factors
for survival in metastatic breast cancer by hormone receptor
status. Breast Cancer Res Treat. 145:503–511. 2014. View Article : Google Scholar : PubMed/NCBI
|
